search icon
  • Print
  • ShareThis
  • Text Size
Sort By:  Relevance | Date
Showing results 1 - 10 of 29.
(0.09 second)
Only results matching the refine constraints are displayed. [Clear]
PDF
IDSA, PIDS, and HIVMA Joint letter to NIH and OHRP on Informed Consent for Use of De-identified Clinical Specimens (PDF)
10,000 infectious diseases physicians and scientists devoted to patient care, disease prevention, public health, education, and research in the area of infectious diseases. ...
http://www.idsociety.org/.../IDSA-PIDS-HIVMA Final Common Rule letter 07-21-1... - 3 pages

Details | Not yet rated

PDF
IDSA Submits Priority ID Research Topics to PCORI (PDF)
IDSA represents more than 10,000 infectious diseases physicians and scientists devoted to patient care, disease prevention, public health, education, and research in the...
http://www.idsociety.org/.../Letters/IDSA ID PCORI topics 05-18-16.pdf - 5 pages

Details | Not yet rated

PDF
IDSA Comments on NSABB Draft Recommendations to Oversee Gain of Function Research of Concern (PDF)
National Science Advisory Board for Biosecurity (NSABB) as it develops formal recommendations on how to assess the risks and benefits of gain-of-function (GOF) research of...
http://www.idsociety.org/.../Letters/IDSA Comments to the NSABB 02222016.pdf - 4 pages

Details | Not yet rated

PDF
IDSA, HIVMA, and PIDS Comments on HHS Notice of Proposed Rule Making to Revise the Common Rule (PDF)
Our societies applaud HHS’s efforts to modernize and simplify Common Rule regulations that reduce burden, delay, and ambiguity for investigators while strengthening the...
http://www.idsociety.org/.../IDSA PIDS HIVMA Comments to Common Rule NPRM 121... - 6 pages

Details | Not yet rated

PDF
IDSA Comments to NSABB on Gain-of-Function Risk-Benefit Assessment (PDF)
The Infectious Diseases Society of America (IDSA) is pleased to offer recommendations to the National Science Advisory Board for Biosecurity (NSABB) as it works with Gryphon...
http://www.idsociety.org/.../Letters/IDSA Comments to NSABB RE GOF 081015.pdf - 4 pages

Details | Not yet rated

PDF
IDSA Comments on NIH Strategic Plan (PDF)
Strategic Plan. As biomedical research has become more interdisciplinary, the need for an objective set of NIH-wide principles to guide cross-cutting research topics has...
http://www.idsociety.org/.../IDSA Comments on NIH Strategic Plan 081415.pdf - 3 pages

Details | Not yet rated

PDF
IDSA, PIDS, and HIVMA Comments to NIH to Improve the Impact and Sustainability of Biomedical Research (PDF)
National Institutes of Health’s (NIH) request for information on optimizing funding policies and other strategies to improve the impact and sustainability of biomedical...
http://www.idsociety.org/.../Joint IDSA-PIDS-HIVMA Letter on NIH Sustaining R... - 5 pages

Details | Not yet rated

PDF
IDSA Comments on the Impact of Select Agent Regulations (PDF)
request for information (RFI) concerning the impact of select agent regulations (SAR). IDSA strongly believes that research conducted with select agents and toxins require...
http://www.idsociety.org/.../IDSA comments on the impact of SAR 03-30-15.pdf - 3 pages

Details | Not yet rated

PDF
IDSA Comments to NIH on the Use of a Single IRB for Multi-Site Research Trials (PDF)
10,000 infectious diseases physicians and scientists devoted to patient care, disease prevention, public health, education, and research in the area of infectious diseases. ...
http://www.idsociety.org/.../IDSA Comments on NIH draft central IRB Policy Fi... - 2 pages

Details | Not yet rated

PDF
IDSA Comments to PCORI (PDF)
The Infectious Diseases Society of America (IDSA) represents over 10,000 infectious diseases physicians and scientists devoted to patient care, disease prevention, public...
http://www.idsociety.org/.../Letters/IDSA Comments to PCORI 091114.pdf - 4 pages

Details | Not yet rated

Refine Your Results:
Topic:
Research & InfrastructureResearch & Infrastructure
Letters To AgenciesLetters To Agencies (29)
Emerging Infections & BiothreatsEmerging Infections &... (4)
Antimicrobial ResistanceAntimicrobial Resistance (3)
Workforce & TrainingWorkforce & Training (2)
Antibiotic Development: 10x'20Antibiotic Development: 10x'20 (2)
 
more
Type of information:
Letters To AgenciesLetters To Agencies
Letters to AgenciesLetters to Agencies (29)
LettersLetters (4)
FDA-Related EffortsFDA-Related Efforts (2)
CommentsComments (1)
 
Year:
2016 (3)
2015 (6)
2014 (2)
2013 (2)
2012 (4)
 
more
Type:
pdfPDF (29)
 
Source:
IDSA WebsiteIDSA Website (29)
 
Powered by Coveo Enterprise Search
Result Page: 1  2  3  [Next]

| HIVMA | Contact Us

© Copyright IDSA 2016 Infectious Diseases Society of America

Full Site Mobile Site